ReviewClinical pharmacology and therapeutics2017

Lessons Learned: Transfer of the High-Definition Circulating Tumor Cell Assay Platform to Development as a Commercialized Clinical Assay Platform.

P Kuhn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.